Diabetes mellitus is a chronic illness managed frequently by the family physician. Along with glycaemic control, consideration for other risk factor reduction for micro- and macrovascular complications of diabetes is important. With the introduction of newer pharmacological agents targeting the different pathophysiological aspects of diabetes, it is important for the family physician to make an informed decision, considering the risks and benefits, when choosing the most suitable therapeutic agent. A patient-centered approach is thus crucial in the management of diabetes. This review article focuses on the latest guidelines and new developments in diabetes management in the recent 1-2 years.